Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (LIFE)
NASDAQ:LIFE
Holding LIFE?
Track your performance easily
LIFE Stock Chart & Stats
Day’s Range$1.82 - $1.95
52-Week Range― - ―
Previous Close$1.85
Volume269.48K
Average Volume (3M)N/A
Market Cap
$125.60M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 14, 2024EPS Estimate
-$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$23.25Price Target Upside1123.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
aTyr Pharma News
PremiumCompany Announcements
aTyr Pharma Stockholders Endorse Leadership and Progress
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
17.75% Other Institutional Investors
82.25% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LIFE FAQ
What was aTyr Pharma’s price range in the past 12 months?
Currently, no data Available
What is aTyr Pharma’s market cap?
Currently, no data Available
When is aTyr Pharma’s upcoming earnings report date?
aTyr Pharma’s upcoming earnings report date is Aug 14, 2024 which is 95 days ago.
How were aTyr Pharma’s earnings last quarter?
aTyr Pharma released its earnings results on May 02, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.25 by $0.02.
Is aTyr Pharma overvalued?
According to Wall Street analysts aTyr Pharma’s price is currently Undervalued.
Does aTyr Pharma pay dividends?
aTyr Pharma does not currently pay dividends.
What is aTyr Pharma’s EPS estimate?
aTyr Pharma’s EPS estimate is -$0.24.
How many shares outstanding does aTyr Pharma have?
Currently, no data Available
What happened to aTyr Pharma’s price movement after its last earnings report?
aTyr Pharma reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.25. Following the earnings report the stock price went up 0.625%.
Which hedge fund is a major shareholder of aTyr Pharma?
Among the largest hedge funds holding aTyr Pharma’s share is Woodline Partners LP. It holds aTyr Pharma’s shares valued at 3M.
---
aTyr Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.25 (1123.68% Upside)
$23.25 (1123.68% Upside)
Blogger Sentiment
Bullish
LIFE Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $123.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 8.7%
Last 30 Days ▲ 8.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-21.88%
12-Months-Change
Fundamentals
Return on Equity
-55.50%
Trailing 12-Months
Asset Growth
-17.24%
Trailing 12-Months
Company Description
aTyr Pharma
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
---
LIFE Earnings Call
Q4 2024
0:00 / 0:00
---
LIFE Stock 12 Month Forecast
Average Price Target
$23.25
▲(1123.68% Upside)
Technical Analysis
Best Analysts Covering LIFE
1 Year
1 Year Success Rate
4/11 ratings generated profit
1 Year Average Return
+3.33%
reiterated a buy rating 6 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of +3.33% per trade.
---